Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE SOUTH KOREA EDITION 2026

South Korea’s
healthtech industry,
in focus.

The companies, capital and talent shaping healthtech in South Korea. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Healthtech Industry Landscape of South Korea
KR
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Healthtech illustration
MEET THE COMPANIES

Explore South Korea’s healthtech leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Healthtech company highlights in South Korea, snapshot 31 August 2026
Company
Lunitlunit.io$133.16M—279—
AItricsaitrics.com$53.74M—37—
CareLabscarelabs.co.kr$48.7M—73—
3billion3billion.io$45.97M—75Financial figure available in RadarView in Radar
NEUROPHETneurophet.com$45.93M—101—
Wellmarker Biowmbio.co$45.2M—58—
AIRS MEDICALairsmed.com$44.48M3 roles63—
Dr. Nowdoctornow.co.kr$39.37M—69—
Medijobmedijob.cc—7 roles——
DeepCardiodeepcardio.com—2 roles——
Avisaivis.kr—1 roles——
Kai Healthkaihealth.tech—1 roles6—
My Doctormy-doctor.io—1 roles21—
NGeneBiongenebio.com—1 roles124—
Weltweltcorp.com—1 roles22—
Boditech Medboditech.co.kr——460Financial figure available in RadarView in Radar
CLASSYSclassys.com——20—
Clinicalclinicaldentium.com——741Financial figure available in RadarView in Radar
Cytogencytogenlab.com——43Financial figure available in RadarView in Radar
Dong-A STdonga-st.com——1,653Financial figure available in RadarView in Radar
Duchem Bioduchembio.com——136—
JEISYS Medicaljeisys.com——197—
Osstem Implanten.osstem.com——2,291—
Vunovuno.co——163Financial figure available in RadarView in Radar
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Healthtech industry KPIs in South Korea

A few useful ratios bring the size of this ecosystem into perspective.

31 August 2026
Hiring participation0.9%

12 of 1,304 tracked companies have open roles.

Funding participation13.3%

174 of 1,304 tracked companies have a recorded round.

Top 3 funding share20.5%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$5M

Midpoint of 141 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 20.5% of disclosed capital, while 86.7% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How South Korea healthtech has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

South Korea healthtech
$0$65.05M$130.09M$195.14M$260.19M2016: $18.7M20162017: $3.97M20172018: $101.81M20182019: $52.26M20192020: $90.44M20202021: $210.66M20212022: $228.23M20222023: $96.6M20232024: $172.88M20242025: $69.13M2025
View the numbers
Annual healthtech funding and company formation in South Korea
YearFunding (USD)FoundedRaising
2016$18.7M895
2017$3.97M874
2018$101.81M1009
2019$52.26M12210
2020$90.44M9712
2021$210.66M8417
2022$228.23M5921
2023$96.6M2319
2024$172.88M2324
2025$69.13M47
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Lunit11.6%
  • AItrics4.7%
  • CareLabs4.2%
  • Other companies79.5%

Funding by stage

239 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel109 45.6%
Series A–B100 41.8%
Series C+ / PE18 7.5%
Grants, debt & other12 5.0%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Post IPO04/2026
NEUROPHET $21.54M

Backed by GVA and Fine Value Asset Management and others.

Series D04/2026
3billion $20.28M

Backed by GVA and Industrial Bank of Korea and others.

Seed04/2026
Stress Solution $2.88M

Backed by Enlight Ventures and Korea Credit Guarantee Fund and others.

Series C03/2026
Mediwhale $13.18M

Backed by Premier Partners and KB Investment and others.

Series B03/2026
LabInCube $9.87M

Backed by Metabiomed and BNH INVESTMENT and others.

Series A02/2026
Leesol $2.07M

Backed by BNK Venture Capital and Spacetime Investment.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series C11/2021
Lunitlunit.io$61M

Backed by Health Quest Capital and Casdin Capital and others.

Series C07/2021
Lunitlunit.io$26M

Backed by Guardant Health and Shinhan Financial Group and others.

Series C01/2020
Lunitlunit.io$26M

Backed by Legend Capital and IMM Investment and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

No reviewed exact national-ID connector has yet been qualified for South Korea; this is a checked implementation boundary, not evidence that filings are absent.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the South Korea companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

278 of these companies (21.3%) publish at least one Android app — 564 apps in all, carrying 42.3M installs between them.

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Healthcare Booking Platforms5221.6M똑닥 - 병원 예약\/접수, 실시간 대기순서 7.6M
Disease Self Management20517.1MBlood Pressure(BP) Diary 3.3M
Healthcare It2086.7M덴티아이경기 670.5K
Wearable Technology1066.7M열나요 - 집에서 시작하는 우리 아이 열관리 1.4M
Fitness & Wellness Tech414.5MSleepisolBio - AI Sleep & Care 1.7M
Mom & Baby Care121.4M베베로그(bebeLog) - 스마트한 육아의 시작 16.4K
Online Health Information41.2MBaby Billy - Pregnancy & Baby 1M
Pediatrics7857.5K아이보리 (산후조리원 신생아 실시간 영상서비스) 845.4K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2023Q2: 112023Q2: 62023Q22023Q3: 32023Q3: 122023Q32023Q4: 122023Q4: 182023Q42024Q1: 102024Q1: 112024Q12024Q2: 142024Q2: 142024Q22024Q3: 122024Q3: 272024Q32024Q4: 82024Q4: 222024Q42025Q1: 152025Q1: 172025Q12025Q2: 52025Q2: 172025Q22025Q3: 82025Q3: 632025Q32025Q4: 122025Q4: 782025Q42026Q1: 72026Q1: 482026Q1

Darker bars are new releases, lighter bars apps updated. 326 of 564 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The South Korea healthtech market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech618
Life sciences408
Consumer digital329
Enterprise software195
Digital diagnostics platforms93
In vitro diagnostics79
Iot in healthcare78
At home diagnostics77
Deep tech74
Saas73
Healthtech saas60
Consumer internet of things60

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

618companies
1.5%have hiring activity

9 companies hiring · $910.64M disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Subscription596
Physical commerce505
E-commerce - product486
Fee-for-service109
Commission on transaction89
E-commerce - service69
Advertising57
Freemium2
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Mergers & acquisitionsclassys.com ↗

Bain Capital LP offloaded an 8.25% stake in South Korea’s medical aesthetics device maker Classys Inc. in an after-hours block trade, raising 324 billion won ($226 million).

IPO activityimagoworks.ai ↗

Imagoworks Inc., a leading AI-powered digital dentistry company, today announced that it has selected Samsung Securities as lead underwriter for its planned initial public offering (IPO) on KOSDAQ, South Korea's technology-focused stock exchange.

Mergers & acquisitionswsgcrest.com ↗

According to sources, WSG Brands has now secured the opportunity to acquire Sanctuary, but is still lining up the money. According to documents, WSG is looking for $70.5 million of investor equity, which must be fully funded by March 25. That includes the $67 million purchase price, along with $3.5 million in closing costs and fees.

Funding roundslabincube.com ↗

LabInCube Secures Strategic Investment from MetaBioMed to Expand MOF Technology into Medical Materials

Funding roundsintegrationcorp.co.kr ↗

Integration raises $18.5M led by Altos Ventures to modernize traditional Korean medicine clinic operations and build global brands.

Funding roundsvuno.co ↗

VUNO announced Tuesday that Smilegate Investment’s 10 billion won ($6.8 million) “Smilegate Innovation Growth Fund” will make a strategic investment, following board approval.

Funding roundsaitrics.com ↗

Nine Korean and foreign venture capital firms and financial institutions invested a total of 35 billion won ($23.7 million) in medical AI company AITRICS, the company announced Monday, marking the completion of its Series C investment round.

Funding roundsnoul.kr ↗

Noul said it will raise 35 billion won ($24.9 million) through a rights offering.

Mergers & acquisitionsmaihub.ai ↗

Korean medical AI company VUNO said it will transfer all technology and business related to its bone age analysis solution, VUNO Med-BoneAge, to fellow medical AI platform developer Maihub for 2.7 billion won ($1.9 million).

Mergers & acquisitionslunit.io ↗

Earlier in June, Lunit acquired Prognosia's 'core technology asset,' according to Lunit's public filing on Aug. 13.

Full recorded event mix

Top 10 categories among 163 recorded events in the 24-month window.

Company announcements
34
Funding rounds
27
Mergers & acquisitions
25
Earnings
22
Contracts
16
Leadership moves
15
IPO activity
9
Capital infusions
5
Regulatory
5
Lawsuit
3
5 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

3 tracked people moves

NEUROPHET ↗
Josh Cohen

Appointment Head of Americas Business

Gyubum Ko

Appointment Independent Board Member

Ha Chang-woo

Appointment Chief Executive Officer

Contract wins

14 recorded customer wins

noul ↗

Customer: Mexico

noul ↗

Customer: panama

Promedius ↗

Customer: Siemens Healthineers ChinaHealthcare

NEUROPHET ↗

Customer: Modawina Medical Equipment TradingMedTech

Lunit ↗

Customer: unihaHealthcare

ATsens ↗

Customer: key U.S. distributorHealthcare / Medical Devices

Regulatory events

5 recorded events

renewed approvalJapan’s Pharmaceuticals and Medical Devices Agency

Neurive ↗

approval granted

Mediwhale ↗

Approved

Mediwhale ↗

De Novo approval pendingUS Food and Drug Administration (FDA)

Litigation

3 tracked suits

Company
cytogen v DuPont Merck Pharmaceutical Co.

failure to meet obligations under a marketing agreement for QuadrametCivil · Filed

Company
cytogen v advanced

settlement of lawsuit over 10-year license agreementCivil · Settled

Earnings pulse

Reported company results in the recorded window.

9companies
21period observations
40.0%median reported growth

Median across 16 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
Na→CLASSYS ↗Announced2026-04-24Not stated in snapshot
CLASSYS→JL Health Participacoes S.A.Announced2026-04-24Not stated in snapshot
WSG→sanctuaryRumored2026-03-10$70.5M
WSG→von dutchCompleted2026-03-10Not stated in snapshot
Maihub→VUNO Med-BoneAgeAnnounced2025-09-11Not stated in snapshot
bain capital→CLASSYS ↗Completed2025-09-08Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

1 postings in the preceding 12 months. The full 1-posting snapshot covers 1 employers.

Expand panel +

Most advertised job titles

No repeated job title is supported by this snapshot.

1 internship postings

0 tracked postings mention remote work.

Skills employers mention

Top skills across 1 tracked postings in the available jobs snapshot.

Network Monitoring
1
Active Directory
1
Http/S
1
Diagnostics
1
Zero Trust
1
Snmp
1
Automation Tools
1
Dns
1
Cisco
1
Windows
1
THE PEOPLE BUILDING THE FIELD

Founders and leaders

609 founders and chief executives across 526 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

28 profiles with education records.

Seoul National University
9
Yonsei University
3
Korea University
3
Carnegie Mellon University
3
University of California (Berkeley)
2
Cornell University
2
Stanford University
1
Duke University
1

Prior employers

2 profiles with prior-work records.

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

270,387 articles in the measured 12-month window.

Expand panel +
270,387articles in the measured year
47,468articles in 2026Q1
32.2%positive tone in the latest complete year

News volume trends

Healthtech coverage across South Korea · articles per complete quarter

038,31576,630114,945153,2602021Q2: 29,1422021Q22021Q3: 32,3912021Q4: 29,7962022Q1: 35,0512022Q2: 34,1142022Q22022Q3: 36,4062022Q4: 53,6082023Q1: 48,6682023Q2: 46,4192023Q22023Q3: 53,2942023Q4: 42,4652024Q1: 50,7182024Q2: 55,4712024Q22024Q3: 55,6572024Q4: 68,3552025Q1: 78,7432025Q2: 52,3242025Q22025Q3: 133,2702025Q4: 42,4452026Q1: 47,4682026Q1
View quarterly article counts
QuarterArticles
2021Q229,142
2021Q332,391
2021Q429,796
2022Q135,051
2022Q234,114
2022Q336,406
2022Q453,608
2023Q148,668
2023Q246,419
2023Q353,294
2023Q442,465
2024Q150,718
2024Q255,471
2024Q355,657
2024Q468,355
2025Q178,743
2025Q252,324
2025Q3133,270
2025Q442,445
2026Q147,468

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
44,049 positive · 31,057 neutral · 23,813 negative
2022
69,456 positive · 48,393 neutral · 41,165 negative
2023
87,702 positive · 60,508 neutral · 42,500 negative
2024
86,423 positive · 95,523 neutral · 48,082 negative
2025
98,606 positive · 150,699 neutral · 57,324 negative

Leading coverage topics

Healthtech coverage across South Korea · ranked by full-period article count.

International And Transnational Geographic Entities300,157 articles in the full recorded period
108,052 recent · 81,361 prior
Geopolitical Disputes And Contested Areas300,153 articles in the full recorded period
108,049 recent · 81,361 prior
Administrative And Political Subdivisions300,136 articles in the full recorded period
108,047 recent · 81,349 prior
International Political Relations23,738 articles in the full recorded period
5,600 recent · 5,642 prior
Security And Defense Policies18,259 articles in the full recorded period
4,165 recent · 4,585 prior
International Relations And Diplomacy16,212 articles in the full recorded period
3,194 recent · 3,754 prior
Trade Policies And Agreements12,583 articles in the full recorded period
6,529 recent · 3,856 prior
International Sports Competitions12,337 articles in the full recorded period
2,678 recent · 1,994 prior
Cryptocurrency Impact On Forex Markets8,427 articles in the full recorded period
2,907 recent · 1,420 prior
Military Technology Advancements6,406 articles in the full recorded period
1,047 recent · 1,372 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Healthtech coverage across South Korea

KeywordRecentPriorChange
countries4,1751,848126%
bilateral trade1,30287449%
trade facilitation commitments64445641%
summit diplomacy49928376%
study overseas447174157%
bilateral trade terms42629743%
stablecoin fx impact42586394%
oil price volatility41764552%
overseas study391168133%
semester abroad353142149%
aircraft wreckage84670-87%
aircraft emergency procedures59550-89%
olympic team selections287501-43%
flight safety measures71492-86%
korean dmz clashes165384-57%

Event and signal lenses

Healthtech coverage across South Korea

All complete annual cohorts shown
Rising

Regulatory Risk

547,067 classified articles

territories, disputed islands, countries

14.9% critical · 9.7% positive
Rising

Funding Momentum

25,850 classified articles

quarterfinals, world cup, currency intervention policies

43.0% critical · 44.6% positive
Rising

Growth

96,315 classified articles

gdp growth rate, gdp acceleration, economic output growth

32.6% critical · 48.0% positive

Healthtech coverage across South Korea. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Healthtech research is working on

53,214 papers in the recorded worldwide scope.

Expand panel +
53,214papers
53,214worldwide comparison pool
—India-affiliated papers

Research orientation

Promising
15,812
Problem-identifying
15,414
Descriptive
9,998
Breakthrough
6,783
Cautionary
3,403
Comparative
1,341
Critical
463

Contribution mix

Empirical
22,567
Methods-led
13,145
Reviews
10,811
Position pieces
6,308
Theoretical
383

Tone counts: 46,301 positive · 2,052 neutral · 4,861 negative.

Common problems researchers identify
15,877 papers · 29.8% of this field
  • Health care5,383 papers
  • Digital health5,157 papers
  • Health informatics3,104 papers
  • Public health2,260 papers
  • Health administration1,986 papers
  • Nursing research1,665 papers
  • Psychological intervention1,634 papers
  • Mental health1,156 papers

Landmark: Implementation strategies: recommendations for specifying and reporting

Cautions
3,403 papers · 6.4% of this field
  • Health care1,001 papers
  • Digital health984 papers
  • Psychological intervention545 papers
  • Health informatics522 papers
  • Mental health342 papers
  • Public health312 papers
  • Health administration310 papers
  • Nursing research229 papers

Landmark: Deep Learning for Health Informatics

Opportunities
22,595 papers · 42.5% of this field
  • Health care5,726 papers
  • Digital health5,168 papers
  • Health informatics2,677 papers
  • Psychological intervention2,251 papers
  • Wearable computer1,817 papers
  • Mental health1,669 papers
  • Public health1,409 papers
  • Intervention1,351 papers

Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science

Leading institutions

University of Toronto
24,168
VA Center for Clinical Management Research
23,746
McMaster University
23,248
VA Ann Arbor Healthcare System
21,768
University College London
21,651
Harvard University
21,597

Leading researchers

Laura J. Damschroder
27,157
Heather Colquhoun
15,523
David C. Aron
14,752
Susan Kirsh
14,676
Rosalind E. Keith
14,545
J Alexander
14,434
Kelly K. O’Brien
14,344
Danielle Levac
14,344

Highly cited breakthrough-labelled papers

  • Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science14,434 citations
  • A Novel Cloud-Based Framework for the Elderly Healthcare Services Using Digital Twin724 citations
  • BSN-Care: A Secure IoT-Based Modern Healthcare System Using Body Sensor Network690 citations
  • The SAIL databank: linking multiple health and social care datasets659 citations
  • Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation547 citations

Common problems researchers identify

42,040 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Health System ResilienceCommon problems researchers identify · 01

Health System Resilience

1,142 papers

19.0% of this theme group

Examines factors and methods for building resilient health care systems and services.

Health informatics (400) · Health administration (281) · Nursing research (250) · Public health (273)

Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience

Health systems resilience in practice: a scoping review to identify strategies for building resilience

View research history
YearShare index
202223.2
202321.1
202427.6
202544.8
Complex Disease Drug DevelopmentCommon problems researchers identify · 02

Complex Disease Drug Development

1,137 papers

18.9% of this theme group

Discusses multi‑target strategies, repurposing, and design challenges for drugs treating complex illnesses.

Drug discovery (321) · Drug (197) · Drug development (103) · Disease (155)

A perspective on multi‐target drug discovery and design for complex diseases

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer

View research history
YearShare index
2022157.3
2023161.8
2024169.7
2025211.5
Digital Health for Universal CoverageCommon problems researchers identify · 03

Digital Health for Universal Coverage

953 papers

15.9% of this theme group

Analyzes how eHealth tools support universal health coverage and influence patient behavior.

Digital health (627) · Health care (357) · Digital transformation (69) · eHealth (97)

Technology and Universal Health Coverage: Examining the role of digital health

Engagement With and Acceptability of Digital Media Platforms for Use in Improving Health Behaviors Among Vulnerable Families: Systematic Rev

View research history
YearShare index
2022538.7
2023553.0
2024540.4
2025843.9
Telehealth Implementation ChallengesCommon problems researchers identify · 04

Telehealth Implementation Challenges

881 papers

14.7% of this theme group

Reviews practical obstacles and evaluation methods for telemedicine and telerehabilitation services.

Telemedicine (604) · Telehealth (394) · Health care (334) · Telerehabilitation (53)

Opportunities and challenges for telehealth within, and beyond, a pandemic

Strategies for Evaluating Telehealth

View research history
YearShare index
2022542.2
2023554.7
2024541.1
2025844.0
Precision Oncology BarriersCommon problems researchers identify · 05

Precision Oncology Barriers

703 papers

11.7% of this theme group

Explores diagnostic, biomarker, and resistance issues limiting personalized cancer treatments.

Precision medicine (480) · Personalized medicine (238) · Disease (116) · Precision oncology (28)

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

Personalizing Oncology: Perspectives and Prospects

View research history
YearShare index
20221255.2
20231115.6
20241012.0
20251296.9
Medical Device Regulation and RiskCommon problems researchers identify · 06

Medical Device Regulation and Risk

655 papers

10.9% of this theme group

Addresses safety, risk analysis, and regulatory gaps for wearable and moderate‑risk medical devices.

Medical device (221) · Wearable computer (50) · Medical equipment (27) · Risk analysis (34)

Energy sources and their development for application in medical devices

Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk Devices

View research history
YearShare index
202240.4
202342.2
202443.7
202572.1
Pandemic‑Driven Telemedicine SurgeCommon problems researchers identify · 07

Pandemic‑Driven Telemedicine Surge

529 papers

8.8% of this theme group

Investigates how COVID‑19 reshaped telemedicine usage and its impact on specialty care.

Pandemic (394) · Coronavirus disease 2019 (274) · 2019-20 coronavirus outbreak (69) · Telemedicine (258)

Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study

Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys

View research history
YearShare index
2022655.3
2023440.6
2024327.7
2025212.1

Cautions

9,548 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Telemedicine Outcome UncertaintyCautions · 01

Telemedicine Outcome Uncertainty

1,188 papers

19.8% of this theme group

Highlights mixed evidence on effectiveness, patient satisfaction, and long‑term outcomes of remote care.

Telemedicine (762) · Telehealth (476) · Telerehabilitation (118) · Health care (319)

The Role of Telemedicine in Improving Healthcare Outcome: A Review

Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions

View research history
YearShare index
202251.7
202348.4
202444.2
202563.5
E‑Health Adoption BarriersCautions · 02

E‑Health Adoption Barriers

1,185 papers

19.8% of this theme group

Identifies technical, infrastructural, and quality‑assessment challenges for digital health in low‑resource settings.

Health informatics (239) · Health administration (157) · Nursing research (113) · Medical device (92)

Challenges of using e-health technologies to support clinical care in rural Africa: a longitudinal mixed methods study exploring primary hea

Development and analysis of quality assessment tools for different types of patient information – websites, decision aids, question prompt l

View research history
YearShare index
202223.2
202321.1
202427.6
202544.8
Pharmacogenomics Translation RisksCautions · 03

Pharmacogenomics Translation Risks

921 papers

15.3% of this theme group

Discusses regulatory, predictive, and methodological hurdles in applying genetic biomarkers to drug development.

Drug discovery (202) · Drug (160) · Pharmacogenomics (109) · Pharmacogenetics (64)

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape

Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologic

View research history
YearShare index
2022154.6
2023158.9
2024165.9
2025206.7
Digital Mental‑Health Intervention LimitsCautions · 04

Digital Mental‑Health Intervention Limits

884 papers

14.7% of this theme group

Examines adoption patterns, efficacy variability, and user‑experience concerns for digital mental‑health tools.

Digital health (480) · Psychological intervention (265) · Mental health (159) · Health care (262)

Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review

Digital Health Interventions for Promoting Healthy Aging: A Systematic Review of Adoption Patterns, Efficacy, and User Experience

View research history
YearShare index
2022790.2
2023807.5
2024810.9
20251159.7
COVID‑19 Telehealth Adoption ConcernsCautions · 05

COVID‑19 Telehealth Adoption Concerns

670 papers

11.2% of this theme group

Explores clinician perspectives and barriers to sustained telemedicine use during and after the pandemic.

Pandemic (431) · Coronavirus disease 2019 (360) · Telemedicine (348) · 2019-20 coronavirus outbreak (77)

Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study

Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study

View research history
YearShare index
2022544.1
2023376.7
2024243.3
2025191.2
Precision Medicine Clinical UptakeCautions · 06

Precision Medicine Clinical Uptake

621 papers

10.3% of this theme group

Analyzes awareness gaps, implementation challenges, and evidence limitations for personalized oncology therapies.

Precision medicine (249) · Personalized medicine (164) · Cancer (103) · Oncology (57)

Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Sur

Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review

View research history
YearShare index
2022767.8
20231043.6
2024798.0
2025771.4
AI Integration Ethical IssuesCautions · 07

AI Integration Ethical Issues

531 papers

8.8% of this theme group

Reviews ethical, bias, and accountability considerations when applying artificial intelligence to precision health.

Applications of artificial intelligence (102) · Transformative learning (77) · Health care (188) · Precision medicine (102)

Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous di

Artificial Intelligence in Medicine: Transforming Diagnosis, Treatment, and Healthcare Delivery

View research history
YearShare index
2022534.7
2023549.6
2024538.1
2025839.2

Opportunities

87,120 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Digital Health Usability AdvancesOpportunities · 01

Digital Health Usability Advances

1,079 papers

18.0% of this theme group

Presents models and design approaches that improve clinical usability of digital health technologies.

Digital health (282) · Health care (348) · Health informatics (142) · Psychological intervention (156)

Development of an Evidence-Based Conceptual Model of the Health Care Sector Under Digital Transformation: Integrative Review

HCI-modelling for improving the clinical usability of digital health technologies

View research history
YearShare index
2022541.3
2023554.6
2024543.2
2025853.3
In‑Silico Drug Discovery ExpansionOpportunities · 02

In‑Silico Drug Discovery Expansion

992 papers

16.5% of this theme group

Highlights computational screening and docking methods accelerating identification of novel therapeutic candidates.

Drug discovery (281) · In silico (99) · Drug (155) · Docking (85)

Exploring Cimetidine\nas a Potential Therapeutic Attenuator\nagainst Amyloid Formation in Parkinson’s Disease: Spectroscopic\nand Microscopi

Design, Synthesis,\nand Biological Evaluation of 5‑Formyl-pyrrolo[3,2‑<i>b</i>]pyridine-3-carboxamides as New Selective, Potent,

View research history
YearShare index
2022167.5
2023172.4
2024180.4
2025218.9
Computational Chemistry for Drug DesignOpportunities · 03

Computational Chemistry for Drug Design

830 papers

13.8% of this theme group

Shows how molecular docking and chemical‑space exploration enhance targeted drug discovery pipelines.

Drug discovery (536) · Computational biology (222) · Drug (224) · Chemical space (66)

Assessing molecular docking tools: understanding drug discovery and design

Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics

View research history
YearShare index
2022281.3
2023298.1
2024330.7
2025367.6
Telehealth for Rehabilitation and Palliative CareOpportunities · 04

Telehealth for Rehabilitation and Palliative Care

824 papers

13.7% of this theme group

Explores remote physical therapy and end‑of‑life communication as emerging telemedicine applications.

Telemedicine (475) · Telehealth (353) · Telerehabilitation (87) · Physical therapy (75)

Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study

Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations

View research history
YearShare index
202251.7
202348.4
202444.2
202563.5
Pharmacogenomics‑Driven Personalized TherapiesOpportunities · 05

Pharmacogenomics‑Driven Personalized Therapies

762 papers

12.7% of this theme group

Describes advances in tailoring treatments to genetic profiles across diverse diseases.

Precision medicine (283) · Personalized medicine (216) · Disease (142) · Pharmacogenomics (61)

Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease

Deep Learning for Precision Medicine: Advancing Personalized Treatment Plans in Oncology

View research history
YearShare index
20221255.2
20231115.6
20241012.0
20251296.9
IoT‑Enabled Wearable MonitoringOpportunities · 06

IoT‑Enabled Wearable Monitoring

762 papers

12.7% of this theme group

Discusses wearable and IoT solutions for continuous patient monitoring, especially in remote settings.

Wearable computer (117) · Medical device (84) · Remote patient monitoring (76) · Internet of Things (49)

Wearable technology. Health-care solutions for a growing global population.

IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas

View research history
YearShare index
202240.5
202342.2
202444.3
202574.3
Biomarker‑Based Cancer PersonalizationOpportunities · 07

Biomarker‑Based Cancer Personalization

751 papers

12.5% of this theme group

Focuses on circulating tumor cell analysis and molecular markers to guide individualized cancer care.

Cancer (241) · Precision medicine (207) · Breast cancer (90) · Lung cancer (44)

Bioinformatics-Based Analysis of Circulating Tumor Cells: A Methodological Overview of Personalized Cancer Treatment

[Molecular biomarkers in breast cancer : advances in precision medicine].

View research history
YearShare index
2022776.6
20231055.1
2024810.2
2025787.3

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising29.7%37.4%
Problem-identifying29.0%9.7%
Descriptive18.8%17.3%
Breakthrough12.7%26.3%
Cautionary6.4%4.4%
Comparative2.5%3.8%
Critical0.9%1.1%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceThe future of digital health with federated learning4,5732.66%2,251 (49.2%)2.66%
Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media2920.17%167 (57.2%)0.17%
Bias & fairnessChallenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fa990.06%45 (45.5%)0.06%
Hardware, e-waste & supply chainE-waste for health: recycling smartphones for health monitoring240.01%7 (29.2%)0.01%
Concentration of compute powerDemonopolizing Medical Knowledge160.01%7 (43.8%)0.01%
Labour & data workNew Work—New Interventions: Digital Occupational Health Interventions and the Co-Creation of a Human-Centered Future of 110.01%6 (54.5%)0.01%
Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT100.01%4 (40.0%)0.01%
Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re30.0%1 (33.3%)0.0%
Water use00.0%0 (%)0.0%

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Healthtech patents in South Korea

Published patent filings in the recorded source window.

Expand panel +
101,861filings 2016–2025
8,000assignees
11,853peak annual filings

Filing momentum

03,4086,81510,22313,6312016: 7,68820162017: 7,9332018: 8,66420182019: 9,6022020: 10,45020202021: 10,7522022: 11,59320222023: 11,5532024: 11,77320242025: 11,8532025

Who files the most

Samsung
17,681
UNIV Korea RES & BUS Found
1,952
Korea Advanced INST SCI & TECH
1,612
LG Electronics
1,599
UNIV Yonsei IACF
1,292
I SENS
1,154
KT & G
1,005
Medison
999
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Healthtech in South Korea: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 31 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon